CAR-T Malignancy Reports Could Temper Excitement For Use Beyond Oncology

 
• By Sue Sutter
  
Magnifying glass
The US FDA is looking closely at 19 reports of T-cell malignancies with approved CAR-T products. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Pink Sheet